Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Randomized Trial of Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Previously Treated Soft Tissue Sarcoma

NCT07547592 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07547592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07547592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Randomized Trial of Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Previously Treated Soft Tissue Sarcoma
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
November 30, 2028
Enrollment
92 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms of connective and soft tissue with an unspecified anatomical site